Take care of your memory everyday.

We present the first electrostimulating medical device targeting brain structures responsible for memory consolidation. Cogniguard® is the first non-invasive home use electronic device dedicated specially for patients suffering from Alzheimer's disease to boost memory and make their life easier.

Neuromedical, Alzhaimer, Leczenie Alzhaimer, Skuteczne leczenie Alzhaimera, Alzhaimer disease

Introducing Cogniguard®

Cogniuguard therapy is first effective treatment for memory disorders ∗
∗ ongoing clinical trials show a significant improvement of memory parameters in more than 60% of cases with no significant side effects.

The treatment of memory disorders is one of the greatest challenges of modern medicine. It is estimated that the number of people affected by this problem globally amounts to nearly 50 million cases and annual costs of treatment exceeds 300 billions USD.

Memory disorders may take various forms ranging from mild cognitive impairment (MCI) to advanced dementia during Alzheimer's disease. Memory disorders can occur at different ages and accompany other disease processes, a particular sample are memory disorders occurring after Covid-19 virus infection.

To date, modern medicine has not developed an effective method for the treatment of memory disorders. Research efforts to develop an effective treatment for memory disorders have been ongoing for a long time, and many of the new therapies are in clinical trials. One of the most promising and clinically effective is Cogniguard Therapy


Cogniguard Therapy is based on a method of neuromodulation of the brain through the vagus nerve. Vagus nerve stimulation has been used in clinical practice for over 25 years and is a safe and effective treatment method approved by the U.S. Food and Drug Administration (FDA) for the treatment of epilepsy, depression, and migraine. Our method uses non-invasive stimulation, i.e. transcutaneous stimulation ensuring high safety of treatment.

For every patient

The Cogniguard device is dedicated for patients with mild cognitive impairment (MCI), specially for patients with Alzheimer’s disease or dementia above 60 years old.


The Cogniguard device will be a pioneering solution on a global scale, introducing a new method of therapy delaying the development or reducing symptoms of the disease.

Easy to use

Cogniguard consists of a headband with a built-in neurostimulator. The device will be working in wireless bluetooth connection to personal mobile devices, what gives great opportunity to monitor treatment compliance.

Alzhaimer device, cogniguard, leczenie alzhaimera, Alzhaimer, urządzenie medyczne,poprawa pamięci


The company was founded in 2015 by an Israeli-Polish team of experts in the field of neurology, neurophysiology, psychiatry, and medical engineering supported by experienced managers. We are currently conducting trials in clinical centres in Poland. We are working with an international network of professionals including academics, new technology specialists, business, and marketing managers. The company holds unique IP developed by internal team of inventors .

 Tamir Ben David - Neuromedical.pl

Dr. Tamir Ben David

Main Project Engineer

Dr Ben David brings over 18 years of top management experience in the medical devices development field and venture capital, including Orad, BioControl, BSP, OB-Tools, Virtual Ports and IHCV. Dr. Ben David filed more than 90 patent applications in the field of medical technologies. Dr. Ben David Holds a Ph.D. in Physics and an MBA from Tel Aviv University.

Adam Broncel - Neuromedical.pl

Dr. Adam Broncel

Medical Director

Dr. Broncel M.D., neurologist. Graduated from Medical University of Lodz in Poland and postgraduate studies in Berkeley, CA, USA. Received PhD in the field of neurology, specialized in neuromodulation, author of many international publications. Experience manager in international R&D projects in the field of experimental neurology. Entrepreneur and co-founder of few international companies.

Yossi Bornstein - Neuromedical.pl

Yossi Bornstein


Yossi Bornstein, the CEO and the founder of SHIZIM, a life science holding company. He is the Founder & Chairman of SHIZIMXL an international medical devices Innovation centers. Yossi is the Chairman of GCP CLINICAL STUDIES LTD., one of the top provider of clinical research services and educational programs in Israel.

Agnieszka Jarecka - Neuromedical.pl

Agnieszka Jarecka

R&D Project Development Manager

Msc at the University of Lodz, Faculty of Management and Marketing, has more than 10 years’ experience in management of R&D international projects. Since 2016 has managed three startups projects from Israel in life-science sector, which have received EU grants. Responsible for cooperating and negotiating with strategic partners and creating policy of the company, involved in all operational and financial activities .

Inzynier Mateusz Broncel - Neuromedical.pl

Mateusz Broncel

Project Backend Engineer

Graduated from Technical University of Science and Technology AGH in Cracow, faculty in Electronics and Telecommunication. Has experience in the field of medical electronics, medical software solutions and backend devlopment. His engineering thesis was aimed at building a fatigue detection system from the recording of multispectral signals.

Profesor Piotr Gałecki - Neuromedical.pl

Prof. Piotr Gałecki

Main Clinical Investigator

Psychiatrist, academic teacher and practitioner. Head of the Department of Adult Psychiatry, Medical University of Lodz. National consultant in the field of psychiatry. Author and co-author of over 300 publications, including combining of psychiatry and psychology.

More about Neuromedical

Check out our publications and achivements

Learn more about us!

Do you want to join the project?

If someone in your family is ill or you would like to test our device yourself, write to us!

Together with us, change the world for the better.